Clinical Trials Browser

Phase 1 × Central Nervous System Neoplasms × Oxaloacetic Acid × Clear all

NCT05720624 2025-10-22

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Phase 1 Withdrawn

Central Nervous System Neoplasms